Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/29/2025

Treatment of IgM Deficiency

Diagnosis and Clinical Presentation

  • Laboratory evaluation should include measurement of immunoglobulin levels, specific antibody production, and evaluation of lymphocyte subpopulations, as recommended by the American Academy of Allergy, Asthma, and Immunology 1

Treatment Approach

Immunoglobulin Replacement Therapy

  • IVIG therapy should be initiated for patients with recurrent bacterial infections, as recommended by the American Academy of Allergy, Asthma, and Immunology 1, 2
  • IVIG therapy should also be considered for patients with life-threatening infections, documented bacterial infection with insufficient response to antibiotic therapy, as recommended by the European Society for Immunodeficiencies 2
  • Monthly IVIG treatment should be continued until immunoglobulin levels reach adequate levels (≥400 mg/dl for IgG), with IgG trough levels monitored monthly during treatment, as recommended by the International Patient Organization for Primary Immunodeficiencies 2

Special Considerations

  • Monitor frequency of infections rather than relying solely on serum immunoglobulin levels to assess treatment efficacy, as recommended by the American College of Allergy, Asthma, and Immunology 2
  • For patients with milder presentations, prophylactic antibiotics can be considered as an alternative first-line treatment option, as recommended by the Infectious Diseases Society of America 2